Abstract:To evaluate the value of radiomics for survival analysis and prediction of glioblastoma (GBM) patients treated with chemoradiation therapy (CRT). Twenty-eight newly diagnosed GBM patients who received CRT at our institution between 2008 and 2014 were retrospectively studied. In addition to demographics (age, race, gender) and clinical parameters (KPS, extent of resection, radiation therapy type, dose and status, whether concurrent temozolomide was adjusted/stopped), 255 imaging features were extracted from 3 gadolinium-enhanced T1 weighted MRIs for 2 regions of interest (ROIs) (the surgical cavity and its surrounding enhancement rim). The 3 MRIs were at post-operation, 1-month and 3-month post-CRT. For the radiomics approach, imaging features comprehensively quantified the intensity, spatial variation (texture), geometric property, and their spatial-temporal changes for the 2 ROIs. Overall survival (OS) and progression-free survival (PFS) were analyzed using univariate and multivariate analysis. Machine learning models (logistic regression (LR), support vector machine (SVM), decision tree (DT), neural network (NN)) were applied to evaluate the survival prediction capability of algorithmically selected features. The number of cases and percentage of cases predicted correctly were collected and AUC (area under the receiver operating characteristic (ROC) curve) were determined after leave-one-out cross-validation. For univariate survival analysis, 28 features (1 demographic, 2 clinical and 25 imaging) were statistically significant (P<0.05) for both OS and PFS. The types of imaging features were volumetric, intensity, geometry, texture and their spatial-temporal changes. For multivariate survival analysis, 14 of the features remained statistically significant (P<0.05) for OS and 20 features remained statistically significant (P<0.01) for PFS. When all the features were used by machine learning models to predict the survival, 24 features were algorithmically selected. High prediction accuracy of OS was achieved by using NN (96%, 27 of 28 cases were correctly predicted, AUC = 0.99), LR (93%, 26 of 28 cases were correctly predicted, AUC = 0.95) and SVM (93%, 26 of 28 cases were correctly predicted, AUC = 0.90). When predicting PFS, NN obtained the highest prediction accuracy (89%, 25 of 28 cases were correctly predicted, AUC = 0.92). In this preliminary study, radiomics approach combined with patients’ demographics and clinical parameters are promising (even MGMT status was not available) for survival analysis and prediction in GBM patients treated with CRT. To achieve more accurate predictions, advanced machine learning models should be considered.

Radiomics analysis of cerebral blood flow suggests a possible link between perfusion homogeneity and poor glioblastoma multiforme prognosis

The Prognostic Value and Biological Significance of MRI CE-T1-based Radiomics Models in CNS5-identified GBM: a Multi-Center Study

Radiomics for Survival Analysis and Prediction in Glioblastoma (GBM)—A Preliminary Study

Radiomics-based survival risk stratification of glioblastoma is associated with different genome alteration

SU-F-R-04: Radiomics for Survival Prediction in Glioblastoma (GBM)

Radiogenomics to characterize the immune-related prognostic signature associated with biological functions in glioblastoma

Radiologically defined ecological dynamics and clinical outcomes in glioblastoma multiforme: preliminary results.

Diffusion heterogeneity and vascular perfusion in tumor and peritumoral areas for prediction of overall survival in patients with high-grade glioma

Identifying spatial imaging biomarkers of glioblastoma multiforme for survival group prediction.

Integrated MRI radiomics, tumor microenvironment, and clinical risk factors for improving survival prediction in patients with glioblastomas

Machine learning-based radiomic, clinical and semantic feature analysis for predicting overall survival and MGMT promoter methylation status in patients with glioblastoma

Perfusion MR prior to radiotherapy is a strong predictor of survival in high-grade gliomas after proton and carbon ion radiotherapy

The Effect of Heterogenous Subregions in Glioblastomas on Survival Stratification: A Radiomics Analysis Using the Multimodality MRI

Reproducible and Interpretable Machine Learning-Based Radiomic Analysis for Overall Survival Prediction in Glioblastoma Multiforme

Radiomic Profiles in Diffuse Glioma Reveal Distinct Subtypes with Prognostic Value

P02.11.B An hypothesis generating study of MRI-Derived Radiomics on tumor and microenvironment tissue heterogeneity to guide post-operative management of glioblastoma: toward personalized radiation treatment volume delineation

Nimg-58. Machine Learning-Generated Whole-Brain Radio-Pathomic Tumor Probability Maps Within Contrast-Enhancement Stratify Survival In Glioblastoma Patients Undergoing Gross-Total Resection

Cluster-based prognostication in glioblastoma: Unveiling heterogeneity based on diffusion and perfusion similarities

Nimg-79. A Radiomic-Risk Score For Survival Prediction In Glioma: A Large Multi-Institutional Retrospective Validation Study

A Radiomics Nomogram Based on Multiparametric MRI Might Stratify Glioblastoma Patients According to Survival.

PO-0958 Mortality Risk Stratification Model Based on Radiomics Only: Analysis of Public Open Access HNC Data